AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2022
Dec 5, 2022
31201_dirs_2022-12-05_aa67043f-4690-42b4-af29-12625e8812bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2022-12-01
Reporting Person: Khayal Tamer I (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-01 | Common Stock | M | 11051 | $2.21 | Acquired | 11051 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-01 | Stock Option (Right to Buy) | $2.21 | M | 11051 | Disposed | 2027-06-22 | Common | |
| Stock (11051) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1300 | Direct |
| Common Stock | 24776 | Indirect |
Footnotes
F1: Shares held by the Khayal Family 2021 Irrevocable Trust were omitted from filings made by the Reporting Person on November 9, 2022, November 14, 2022 and November 16, 2022.
F2: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20